Detalhe da pesquisa
1.
Timing of exercise therapy when initiating adjuvant chemotherapy for breast cancer: a randomized trial.
Eur Heart J
; 44(46): 4878-4889, 2023 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36806405
2.
Hidden estrogen production from ovarian remnants leading to progression of disease in metastatic breast cancer.
Breast J
; 24(4): 642-643, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29357201
3.
A phase I trial of ganetespib in combination with paclitaxel and trastuzumab in patients with human epidermal growth factor receptor-2 (HER2)-positive metastatic breast cancer.
Breast Cancer Res
; 19(1): 89, 2017 Aug 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28764748
4.
Phase II trial of a novel capecitabine dosing schedule in combination with lapatinib for the treatment of patients with HER2-positive metastatic breast cancer.
Breast Cancer Res Treat
; 131(1): 111-6, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21898114
5.
A pilot study of dose-dense adjuvant paclitaxel without growth factor support for women with early breast carcinoma.
Breast Cancer Res Treat
; 115(3): 609-12, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18751888
6.
A phase II trial of erlotinib in combination with bevacizumab in patients with metastatic breast cancer.
Clin Cancer Res
; 14(23): 7878-83, 2008 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19047117
7.
Prolonged dose-dense epirubicin and cyclophosphamide followed by paclitaxel in breast cancer is feasible.
Clin Breast Cancer
; 8(5): 418-24, 2008 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-18952555
8.
Increased dose density is feasible: a pilot study of adjuvant epirubicin and cyclophosphamide followed by paclitaxel, at 10- or 11-day intervals with filgrastim support in women with breast cancer.
Clin Cancer Res
; 13(1): 223-7, 2007 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17200358
9.
Phase II Study of Paclitaxel and Dasatinib in Metastatic Breast Cancer.
Clin Breast Cancer
; 18(5): 387-394, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29680193
10.
Pharmacokinetics and toxicity of weekly docetaxel in older patients.
Clin Cancer Res
; 12(20 Pt 1): 6100-5, 2006 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17062686
11.
A prospective, longitudinal study of the functional status and quality of life of older patients with breast cancer receiving adjuvant chemotherapy.
J Am Geriatr Soc
; 54(7): 1119-24, 2006 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-16866685
12.
Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study.
J Am Geriatr Soc
; 54(6): 925-31, 2006 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-16776787
13.
A phase I study of cetuximab/paclitaxel in patients with advanced-stage breast cancer.
Clin Breast Cancer
; 7(3): 270-7, 2006 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16942645
14.
A Pilot Study of Dose-Dense Paclitaxel With Trastuzumab and Lapatinib for Node-negative HER2-Overexpressed Breast Cancer.
Clin Breast Cancer
; 16(2): 87-94, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26454612
15.
A phase II trial of gemcitabine in patients with metastatic breast cancer previously treated with an anthracycline and taxane.
Clin Breast Cancer
; 6(1): 55-60, 2005 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15899073
16.
Phase II study of celecoxib and trastuzumab in metastatic breast cancer patients who have progressed after prior trastuzumab-based treatments.
Clin Cancer Res
; 10(12 Pt 1): 4062-7, 2004 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15217939
17.
Phase II study of feasibility of dose-dense FEC followed by alternating weekly taxanes in high-risk, four or more node-positive breast cancer.
Clin Cancer Res
; 10(17): 5754-61, 2004 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15355903
18.
Phase II study of paclitaxel given once per week along with trastuzumab and pertuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer.
J Clin Oncol
; 33(5): 442-7, 2015 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-25547504
19.
A phase II open-label study of ganetespib, a novel heat shock protein 90 inhibitor for patients with metastatic breast cancer.
Clin Breast Cancer
; 14(3): 154-60, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24512858
20.
Breast implant foreign body reaction mimicking breast cancer recurrence on FDG PET/CT.
Clin Nucl Med
; 38(6): 480-1, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23640240